2021
DOI: 10.1016/j.phytochem.2020.112578
|View full text |Cite
|
Sign up to set email alerts
|

2-(2-Phenylethyl)chromone derivatives: Promising α-glucosidase inhibitors in agarwood from Aquilaria filaria

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(9 citation statements)
references
References 29 publications
0
9
0
Order By: Relevance
“…6 The importance of agarwood in traditional medicine has attracted widespread attention over the past decades. A range of bioactivities, including α-glucosidase inhibitory effects, 7,8 anti-inflammatory, 9,10 cytotoxicity, 11,12 antimicrobial, 13 neuroprotective 14 and acetyl-cholinesterase inhibitory effects 15 have been reported for the compounds or extracts of agarwood. 16 Phytochemical investigation disclosed that agarwood contains two major types of components, namely, sesquiterpenes and 2-(2-phenethyl)chromones.…”
Section: Introductionmentioning
confidence: 99%
“…6 The importance of agarwood in traditional medicine has attracted widespread attention over the past decades. A range of bioactivities, including α-glucosidase inhibitory effects, 7,8 anti-inflammatory, 9,10 cytotoxicity, 11,12 antimicrobial, 13 neuroprotective 14 and acetyl-cholinesterase inhibitory effects 15 have been reported for the compounds or extracts of agarwood. 16 Phytochemical investigation disclosed that agarwood contains two major types of components, namely, sesquiterpenes and 2-(2-phenethyl)chromones.…”
Section: Introductionmentioning
confidence: 99%
“…These therapeutic drugs have been widely used in clinical trials because of their own characteristics in hypoglycemic control. For example, α-glucosidase inhibitors have been used to control postprandial glucose levels caused by type 2 diabetes since 1990 (Ríos et al, 2015;Flores-Bocanegra et al, 2017;Santos et al, 2018;Dhameja and Gupta, 2019;Usman et al, 2019;Mi et al, 2021;Tuyen et al, 2021). Acarbose (Chiasson et al, 2002) and miglitol (Satoru et al, 2015), which were clinically used for treating type 2 diabetes, may control blood glucose levels by targeting α-amylases and α-glucosidases (Lyann et al, 2010;Ren et al, 2011).…”
Section: Introductionmentioning
confidence: 99%
“…The anti‐inflammatory, [7,38–51] AChE inhibitory, [10,42,47,48,52–55] antioxidant, [9,17] cytotoxic, [6,10,54,56,57] PPARγ partial agonist, [58] tyrosinase inhibitory, [59] neuroprotective, [5,60] α ‐glucosidase inhibitory, [61,62] and antibacterial activities [10,6,54,63] of various FHPECs.…”
Section: Multi‐bioactivities Of Pec Derivativesmentioning
confidence: 99%